Dr. Richert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5630 Wisconsin Avenue
Apt 606
Chevy Chase, MD 20815Phone+1 202-288-0872
Summary
- John Richert, MD is a neurologist and neuroimmunologist based in Chevy Chase, MD. He completed his medical education at the University of Rochester School of Medicine and Dentistry in 1970 and completed his residency in neurology at the Mayo Clinic in 1977. Dr. Richert held several notable positions at Georgetown University Medical Center from 1980 to 2005, including as Microbiology & Immunology Department Chair and member of the hospital board of directors. He then served as Executive Vice President for Research & Clinical Programs at the National Multiple Sclerosis Society and Neurology Vice President at Biogen Inc. He has served as a biotech consultant at Richert Partners LLC since 2015. His research work resulted in over 120 publications on T cell immunology, gene expression, and therapy in multiple sclerosis.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1974 - 1977
- University of Rochester School of Medicine and DentistryClass of 1970
Certifications & Licensure
- MD State Medical License 1980 - 2025
- DC State Medical License 1981 - 2022
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 2 citationsProof of concept studies for tissue-protective agents in multiple sclerosisLahar R Mehta, Steven R. Schwid, Douglas L. Arnold, Gary Cutter, S. Aradhye
Multiple Sclerosis. 2009-05-01 - 440 citationsDifferential diagnosis of suspected multiple sclerosis: a consensus approachDavid Miller, Brian G. Weinshenker, Massimo Filippi, Brenda Banwell, Jeffrey A. Cohen
Multiple Sclerosis. 2008-11-01 - 60 citationsMost patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosisElliot M. Frohman, Eva Havrdova, Fred D. Lublin, Frederik Barkhof, A. Achiron
Archives of Neurology. 2006-04-01
Grant Support
- Development Of T Cell Immunity To Viral And AutoantigensNational Institute Of Allergy And Infectious Diseases1988–1992
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: